Revenue: The sum of all revenue fields included for a company's operating activities.
Tonix Pharmaceuticals Holding Corp. (TNXP) had Revenue of $2.00M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
|
Revenue |
$2.00M |
$-28.27M |
|
$3.27M |
|
$-1.27M |
|
$30.29M |
|
$-28.30M |
|
$0.02M |
|
$-28.27M |
|
$-28.27M |
|
$-28.27M |
|
$-28.27M |
|
$-28.27M |
|
$-28.27M |
|
$-28.30M |
|
$-27.81M |
|
7.33M |
|
7.33M |
|
$-3.86 |
|
$-3.86 |
|
| Balance Sheet Financials | |
$143.53M |
|
$42.34M |
|
$43.82M |
|
$187.36M |
|
$19.06M |
|
-- |
|
$0.30M |
|
$19.36M |
|
$168.00M |
|
$167.88M |
|
$168.00M |
|
7.55M |
|
| Cash Flow Statement Financials | |
$-31.41M |
|
$-2.54M |
|
$60.53M |
|
$99.68M |
|
$126.24M |
|
$26.56M |
|
$2.31M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.53 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-63.76% |
|
-1416.22% |
|
-1416.22% |
|
-- |
|
-1415.02% |
|
-1415.02% |
|
$-31.95M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.55 |
|
0.86 |
|
104.50 |
|
-16.83% |
|
-16.84% |
|
-15.09% |
|
-16.83% |
|
$22.26 |
|
$-4.36 |
|
$-4.29 |
|